A detailed history of Concourse Financial Group Securities, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 5,579 shares of DXCM stock, worth $384,448. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,579
Previous 7,727 27.8%
Holding current value
$384,448
Previous $876,000 57.42%
% of portfolio
0.02%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$64.0 - $116.06 $137,472 - $249,296
-2,148 Reduced 27.8%
5,579 $373,000
Q2 2024

Jul 23, 2024

SELL
$110.31 - $140.45 $146,381 - $186,377
-1,327 Reduced 14.66%
7,727 $876,000
Q1 2024

Apr 30, 2024

SELL
$114.22 - $140.1 $67,960 - $83,359
-595 Reduced 6.17%
9,054 $1.26 Million
Q4 2023

Feb 07, 2024

BUY
$75.49 - $124.16 $37,443 - $61,583
496 Added 5.42%
9,649 $1.2 Million
Q3 2023

Oct 25, 2023

BUY
$86.06 - $137.93 $62,823 - $100,688
730 Added 8.67%
9,153 $853,000
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $34,753 - $40,472
-309 Reduced 3.54%
8,423 $1.08 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $33,904 - $40,071
-326 Reduced 3.6%
8,732 $1.01 Million
Q4 2022

Jan 30, 2023

SELL
$84.98 - $122.67 $120,586 - $174,068
-1,419 Reduced 13.54%
9,058 $0
Q3 2022

Nov 15, 2022

SELL
$76.35 - $94.18 $53,521 - $66,020
-701 Reduced 6.27%
10,477 $844,000
Q2 2022

Aug 09, 2022

BUY
$67.99 - $132.89 $567,512 - $1.11 Million
8,347 Added 294.84%
11,178 $833,000
Q1 2022

May 09, 2022

SELL
$94.08 - $130.2 $167,838 - $232,276
-1,784 Reduced 38.66%
2,831 $1.45 Million
Q4 2021

Feb 07, 2022

BUY
$129.87 - $162.82 $13,376 - $16,770
103 Added 2.28%
4,615 $2.48 Million
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $12,591 - $16,895
118 Added 2.69%
4,512 $2.47 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $26,807 - $35,724
331 Added 8.15%
4,394 $469,000
Q1 2021

May 13, 2021

BUY
$84.79 - $104.74 $111,244 - $137,418
1,312 Added 47.69%
4,063 $1.46 Million
Q4 2020

Feb 02, 2021

BUY
$78.0 - $104.5 $45,942 - $61,550
589 Added 27.24%
2,751 $1.02 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $48,710 - $57,604
510 Added 30.87%
2,162 $891,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $34,912 - $58,674
557 Added 50.87%
1,652 $670,000
Q1 2020

May 13, 2020

BUY
$47.79 - $75.63 $15,101 - $23,899
316 Added 40.56%
1,095 $295,000
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $12,340 - $19,306
337 Added 76.24%
779 $170,000
Q3 2019

Nov 13, 2019

BUY
$35.53 - $43.8 $14,460 - $17,826
407 Added 1162.86%
442 $66,000
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $982 - $1,336
35 New
35 $4,000
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $0 - $0
0 New
0 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.